COMy 2023 | Approaching lenalidomide-refractory multiple myeloma: unmet needs and ongoing trials
Luciano Costa
• 13 May 2023
Luciano Costa, MD, PhD, UAB School of Medicine, Birmingham, AL, shares some insights into the challenges with approaching patients with lenalidomide-refractory multiple myeloma, highlighting current treatment strategies for these patients. Dr Costa then goes on to discuss novel approaches being explored, drawing focus on the excitement surrounding the CARTITUDE-4 trial (NCT04181827). This interview took place at the 9th World Congress on Controversies in Multiple Myeloma (COMy) 2023, held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
